No Matches Found
No Matches Found
No Matches Found
SIGA Technologies, Inc.
SIGA Technologies Hits 52-Week Low at $3.01 Amid Financial Struggles
SIGA Technologies, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company reported a 73.6% drop in net sales and consecutive quarterly losses, alongside a market capitalization of USD 380 million, raising concerns about its future in the competitive pharmaceutical sector.
SIGA Technologies Hits New 52-Week Low at $3.40 Amid Sales Decline
SIGA Technologies, Inc. has hit a new 52-week low, reflecting a challenging year marked by a significant decline in stock price and a 73.6% drop in net sales. The company reported a pre-tax loss and negative operating cash flow, highlighting ongoing financial struggles in a competitive market.
SIGA Technologies Hits 52-Week Low at $3.56 Amid Financial Struggles
SIGA Technologies, Inc. has hit a new 52-week low, reflecting a challenging year marked by a significant decline in stock price and a 73.6% drop in net sales. The company reported a pre-tax loss and negative operating cash flow, indicating ongoing financial struggles and concerns about its market position.
SIGA Technologies Hits 52-Week Low at $3.88 Amidst Financial Struggles
SIGA Technologies, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company reported a 73.6% drop in net sales, resulting in disappointing quarterly results and a negative pre-tax profit. Its market capitalization stands at USD 380 million.
Is SIGA Technologies, Inc. technically bullish or bearish?
As of October 3, 2025, SIGA Technologies, Inc. has a mildly bullish trend, supported by bullish MACD and moving averages, despite mixed signals from other indicators and underperformance over the 3- and 5-year periods.
Is SIGA Technologies, Inc. technically bullish or bearish?
As of October 3, 2025, SIGA Technologies, Inc. has a mildly bullish trend with positive momentum indicated by MACD and moving averages, despite mixed signals from KST and a mildly bearish OBV, while year-to-date it has outperformed the S&P 500 but underperformed over the past three years.
Is SIGA Technologies, Inc. technically bullish or bearish?
As of August 6, 2025, SIGA Technologies, Inc. has a bullish technical trend supported by positive MACD and moving averages, outperforming the S&P 500 year-to-date with a 47.59% return, though it has underperformed over longer periods.
Is SIGA Technologies, Inc. overvalued or undervalued?
As of June 30, 2025, SIGA Technologies, Inc. is considered an attractive investment due to its low P/E ratio of 9, favorable EV to EBITDA of 4.72, strong ROCE of 103.73%, and a year-to-date return of 47.59%, outperforming the S&P 500.
Is SIGA Technologies, Inc. overvalued or undervalued?
As of March 11, 2025, SIGA Technologies, Inc. is considered attractive due to its undervalued status, with a P/E ratio of 9, significantly lower than the industry average, and strong operational efficiency indicated by a ROCE of 103.73% and ROE of 22.45%.
Is SIGA Technologies, Inc. technically bullish or bearish?
As of May 9, 2025, SIGA Technologies, Inc. is in a mildly bearish trend, influenced by daily moving averages and monthly MACD signals, despite some mildly bullish indicators on the weekly timeframe.
Who are in the management team of SIGA Technologies, Inc.?
As of March 2022, the management team of SIGA Technologies, Inc. includes Dr. Eric Rose (Chairman), Dr. Phillip Gomez (CEO), and several independent directors: Mr. Julian Nemirovsky, Mr. James Antal, Mr. Thomas Constance, Ms. Julie Kane, and Mr. Joseph Marshall. They oversee the company's operations and strategic direction.
What does SIGA Technologies, Inc. do?
SIGA Technologies, Inc. is a pharmaceutical company focused on health security, primarily developing treatments for smallpox. As of March 2025, it reported net sales of $7 million and has a market cap of $450.08 million.
How big is SIGA Technologies, Inc.?
As of Jun 18, SIGA Technologies, Inc. has a market capitalization of 450.08 million, with net sales of 120.33 million and a net profit of 48.52 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
